Table 3.
Ten most prevalent conditions and associated comorbidities of the total cohort and by SMI diagnosis
| Condition | Prevalence | Mean # of comorbidities | Three most frequent associated comorbidities | |||
| Total | – | 0.74 | 1. Diabetes (15.3%) | 2. HTN (14.5%) | 3. Asthma (9.8%) | |
| SSD | – | 0.77 | 1. Diabetes (17.0%) | 2. HTN (15.9%) | 3. Asthma (9.9%) | |
| BD | – | 0.64 | 1. Diabetes (10.7%) | 2. HTN (10.4%) | 3. Asthma (9.6%) | |
| Diabetes | Total | 15.3% | 2.35 | 1. HTN (42.1%) | 2. Asthma (16.9%) | 3. Arthritis (13.2%) |
| SSD | 17.0% | 2.33 | 1. HTN (42.9%) | 2. Asthma (16.3%) | 3. Arthritis (12.7%) | |
| BD | 10.7% | 2.45 | 1. HTN (38.3%) | 2. Asthma (19.5%) | 3. Arthritis (15.5%) | |
| Hypertension | Total | 14.5% | 2.50 | 1. Diabetes (44.5%) | 2. Asthma (16.3%) | 3. Arthritis (15.2%) |
| SSD | 15.9% | 2.47 | 1. Diabetes (45.7%) | 2. Asthma (16.1%) | 3. Arthritis (14.7%) | |
| BD | 10.4% | 2.62 | 1. Diabetes (39.2%) | 2. Arthritis (17.3 %) | 3. Asthma (17.1%) | |
| Asthma | Total | 9.8% | 2.27 | 1. Diabetes (26.3%) | 2. HTN (24.0%) | 3. Arthritis (11.9%) |
| SSD | 9.9% | 2.27 | 1. Diabetes (27.9%) | 2. HTN (25.9%) | 3. Eczema (11.2%) | |
| BD | 9.6% | 2.29 | 1. Diabetes (21.6%) | 2. HTN (18.6%) | 3. Arthritis (15.1%) | |
| Arthritis | Total | 5.5% | 2.78 | 1. HTN (40.5%) | 2. Diabetes (37.1%) | 3. Asthma (21.5%) |
| SSD | 5.4% | 2.78 | 1. HTN (43.4%) | 2. Diabetes (39.9%) | 3. Asthma (19.9%) | |
| BD | 5.6% | 2.80 | 1. HTN (32.1%) | 2. Diabetes (29.4%) | 3. Asthma (25.8%) | |
| Epilepsy | Total | 4.6% | 2.40 | 1.HTN (25.5%) | 2.Diabetes (24.8%) | 3.Asthma (21.4%) |
| SSD | 5.0% | 2.42 | 1. HTN (27.3%) | 2. Diabetes (26.4%) | 3. Asthma (21.8%) | |
| BD | 3.3% | 2.31 | 1. Asthma (19.7%) | 2. Diabetes (17.7%) | 2. HTN (17.7%) | |
| CVA | Total | 4.2% | 2.89 | 1. HTN (42.3%) | 2. Diabetes (38.6%) | 3. Asthma (15.4%) |
| SSD | 4.4% | 2.83 | 1. HTN (42.8%) | 2. Diabetes (38.9%) | 3. Asthma (14.0%) | |
| BD | 3.5% | 3.09 | 1. HTN (40.6%) | 2. Diabetes (37.4%) | 3. Asthma (21.9) | |
| Eczema | Total | 3.5% | 2.50 | 1. Asthma (32.5%) | 2. Diabetes (26.9%) | 3. HTN (23.1%) |
| SSD | 3.7% | 2.45 | 1. Asthma (30.3%) | 2. Diabetes (28.4%) | 3. HTN (22.5%) | |
| BD | 3.1% | 2.64 | 1. Asthma (40.1%) | 2. HTN (24.8%) | 3. Diabetes (21.9%) | |
| Migraine | Total | 3.2% | 2.20 | 1. Asthma (23.6%) | 2. Diabetes (20.0%) | 3. HTN (18.4%) |
| SSD | 2.9% | 2.23 | 1. Diabetes (23.4%) | 2. Asthma (21.5%) | 3.HTN (20.2%) | |
| BD | 4.3% | 2.15 | 1. Asthma (27.6%) | 2. HTN (15.1%) | 3. Arthritis (14.1%) | |
| Ischaemic heart disease | Total | 3.2% | 3.27 | 1. HTN (49.0%) | 2. Diabetes (43.3%) | 3. Asthma (20.3%) |
| SSD | 3.3% | 3.28 | 1. HTN (51.0%) | 2. Diabetes (44.6%) | 3. Asthma (20.2%) | |
| BD | 2.8% | 3.24 | 1. HTN (42.1%) | 2. Diabetes (38.9%) | 3. Arthritis (22.2%) | |
| COPD | Total | 2.7% | 3.22 | 1. HTN (39.7%) | 2. Diabetes (38.9%) | 3. Asthma (35.7%) |
| SSD | 2.6% | 3.20 | 1. Diabetes (41.2%) | 2. HTN (39.2%) | 3. Asthma (35.7%) | |
| BD | 3.0% | 3.25 | 1. HTN (41.0%) | 2.Asthma (35.8%) | 3. Diabetes (32.8%) | |
BD, Bipolar disorders; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; HTN, hypertension; SMI, severe mental illness; SSD, schizophrenia Spectrum disorders.